Pivotal Research Upgrades USANA Health Sciences Inc. (USNA) to Buy
Pivotal Research upgraded USANA Health Sciences Inc. (NYSE: USNA) from Hold to Buy with a price target of $200. Analyst ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
